Literature DB >> 3718428

Effect of acute hypoxia on cardiac function in alloxan-diabetic dogs.

M Z Koltai, M Wagner, I Balogh, V Kiss, A Köszeghy, G Pogátsa.   

Abstract

The aim of the present study was to examine the left ventricular and haemodynamic parameters during acute hypoxia induced by carbon monoxide intoxication and/or after norepinephrine administration in metabolically healthy and alloxan-diabetic dogs. In metabolically healthy animals after carbon monoxide intoxication followed by norepinephrine administration myocardial oedema occurred with a concomitant elevation of diastolic stiffness in the left ventricular wall, resulting in impaired cardiac performance. In the alloxan-diabetic animals no myocardial oedema developed and therefore no further increase of the originally elevated left ventricular diastolic stiffness could be observed. Close correlations were demonstrable between the enhanced water content and diastolic stiffness of the left ventricular wall in metabolically healthy animals as well as between the myocardial contractile force and cardiac output index in both control and diabetic dogs. In contrast to the controls, following norepinephrine administration per se decrease of cardiac performance could be observed in the alloxan-diabetic animals. Based on these results, it can be concluded that an increase of left ventricular diastolic stiffness impairs the cardiac performance in acute hypoxia following norepinephrine administration both in control and in diabetic animals, even if different reasons are responsible for it.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718428     DOI: 10.1007/bf01907431

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  26 in total

1.  Specific determination of blood glucose with o-toluidine.

Authors:  A HYVARINEN; E A NIKKILA
Journal:  Clin Chim Acta       Date:  1962-01       Impact factor: 3.786

2.  [Critical study of the intravenous hyperglycemic triangle in normal man and determination of a "carbohydrate assimilation coefficient"].

Authors:  V CONARD; J R FRANCKSON; P A BASTENIE; J KESTENS; L KOVACS
Journal:  Arch Int Pharmacodyn Ther       Date:  1953-04

3.  The role of myocardial edema in the left ventricular diastolic stiffness.

Authors:  G Pogátsa; E Dubecz; G y Gábor
Journal:  Basic Res Cardiol       Date:  1976 May-Jun       Impact factor: 17.165

4.  Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man.

Authors:  G Diamond; J S Forrester
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

Review 5.  Diabetes and hypertensive vascular disease. Mechanisms and treatment.

Authors:  A R Christlieb
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

6.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

Review 7.  Deterioration of the microcirculation in diabetes.

Authors:  D E McMillan
Journal:  Diabetes       Date:  1975-10       Impact factor: 9.461

Review 8.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

9.  Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode.

Authors:  U Ewald; T Tuvemo; G Rooth
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

10.  Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity.

Authors:  P Dandona; I M James; P A Newbury; M L Woollard; A G Beckett
Journal:  Br Med J       Date:  1978-07-29
View more
  1 in total

1.  The diabetic heart: A review of the lifework of Sophie Maria Koltai.

Authors:  Sophie M Koltai; Erzsébet Kocsis; Ildikó Pósa; Pál Hadházy; György Jermendy; Gábor Pogátsa
Journal:  Exp Clin Cardiol       Date:  2002
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.